Association with Hsp90 Inhibits Cbl-mediated Down-regulation of Mutant Epidermal Growth Factor Receptors.
From: Department of Medicine, Breast Cancer Research Program, Vanderbilt-Ingram Comprehensive Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-6307, USA.
Cancer research
- Publish Date: Jul 2006
- ISSN: 0008-5472
- Volume: 66
- Issue: 14
- Pages: 6990-7
- Medium: Print
- Language: English
- Citation (JAMA): Yang Seungchan, Qu Shimian, Perez-Tores Marianela, et al. Association with Hsp90 Inhibits Cbl-mediated Down-regulation of Mutant Epidermal Growth Factor Receptors.. Cancer Res. Jul 2006;66:6990-7
Abstract
Activating mutations in the epidermal growth factor receptor (EGFR), localized in the activation loop within the kinase domain, have been discovered in non-small cell lung cancers (NSCLC). Most of these mutants are exquisitely sensitive to EGFR tyrosine kinase inhibitors, suggesting that they generate receptor dependence in the cancers that express them. 32D cells stably expressing EGFR-L861Q and EGFR-L858R but not wild-type EGFR exhibited ligand-independent receptor phosphorylation and viability. Ligand-induced receptor down-regulation (LIRD) was impaired in mutant-expressing cells. The EGFR mutants were constitutively associated with the E3 ubiquitin ligase Cbl but did not associate with the adaptor protein CIN85 on the addition of ligand. Inhibition of HSP90 activity with geldanamycin restored Cbl function as indicated by receptor ubiquitination and LIRD. These results suggest that EGFR mutants form defective endocytic complexes. In addition, HSP90 plays a role in maintaining the functional conformation of EGFR mutants and protecting activated receptors from LIRD.
Mesh Headings (Keywords): Animals, Cell Survival, Down-Regulation, Female, Gene Expression Regulation, Neoplastic, HSP90 Heat-Shock Proteins, Humans, Ligands, Lung Neoplasms, Mice, Mice, Inbred BALB C, Mutation, Oncogene Protein v-cbl, Receptor, Epidermal Growth Factor, Transfection, Transplantation, Heterologous, Ubiquitin
Check for Full Text / PubMed Unique Identifier (PMID): 16849543
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.